Table 4.
Outcomes | No of studies | No of patients
|
OR/WMD | 95% CI | P-value | I2 (%) | |
---|---|---|---|---|---|---|---|
ET | OT | ||||||
| |||||||
TT | |||||||
Operative time | 4 | 269 | 410 | 47.40 | 34.18, 60.61 | <0.00001 | 84 |
No of retrieved LNs | 4 | 269 | 410 | −0.10 | −0.50, 0.30 | 0.63 | 0 |
Blood loss | 2 | 125 | 225 | 2.35 | −7.27, 11.97 | 0.63 | 79 |
Volume of drainage | 2 | 145 | 240 | 100.31 | −33.67, 234.29 | 0.14 | 94 |
Hospitalization period | 2 | 145 | 240 | 0.33 | 0.10, 0.56 | 0.005 | 0 |
Transient RLN palsy | 4 | 269 | 410 | 1.58 | 0.66, 3.79 | 0.31 | 0 |
Permanent RLN palsy | 3 | 194 | 287 | 1.89 | 0.49, 7.33 | 0.36 | 20 |
Transient hypocalcemia | 3 | 194 | 287 | 1.48 | 0.68, 3.20 | 0.32 | 70 |
Permanent hypocalcemia | 3 | 194 | 287 | 1.35 | 0.46, 3.99 | 0.58 | 0 |
Hematoma or bleeding | 3 | 219 | 308 | 2.93 | 0.61, 14.02 | 0.18 | 0 |
Seroma | 2 | 170 | 261 | 0.67 | 0.10, 4.55 | 0.68 | 0 |
LTT | |||||||
Operative time | 4 | 148 | 166 | 45.96 | 29.33, 62.59 | <0.00001 | 90 |
No of retrieved LNs | 4 | 203 | 364 | −0.89 | −2.48, 0.70 | 0.27 | 90 |
Blood loss | 2 | 54 | 65 | 6.52 | −0.72, 13.76 | 0.08 | 46 |
Duration of drainage | 2 | 54 | 65 | 2.20 | 1.82, 2.59 | <0.00001 | 0 |
Volume of drainage | 2 | 54 | 65 | 114.99 | 99.74, 130.24 | <0.00001 | 0 |
Hospitalization period | 3 | 114 | 136 | 0.81 | −0.19, 1.82 | 0.11 | 95 |
Transient RLN palsy | 4 | 186 | 358 | 2.83 | 1.26, 6.36 | 0.01 | 44 |
Permanent RLN palsy | 3 | 152 | 328 | 5.29 | 0.54, 52.22 | 0.15 | 0 |
Transient hypocalcemia | 2 | 54 | 65 | 0.31 | 0.07, 1.36 | 0.12 | 0 |
Hematoma or bleeding | 4 | 148 | 166 | 2.20 | 0.62, 7.84 | 0.22 | 0 |
Abbreviations: ET, endoscopic thyroidectomy; LN, lymph node; LTT, less than total thyroidectomy; OT, open thyroidectomy; RLN, recurrent laryngeal nerve; TT, total thyroidectomy; WMD, weighted mean difference.